HIF-1α Protects Against Oxidative Stress by Directly Targeting Mitochondria
Overview
Cell Biology
Endocrinology
Authors
Affiliations
The transcription factor hypoxia inducible factor-1α (HIF-1α) mediates adaptive responses to oxidative stress by nuclear translocation and regulation of gene expression. Mitochondrial changes are critical for the adaptive response to oxidative stress. However, the transcriptional and non-transcriptional mechanisms by which HIF-1α regulates mitochondria in response to oxidative stress are poorly understood. Here, we examined the subcellular localization of HIF-1α in human cells and identified a small fraction of HIF-1α that translocated to the mitochondria after exposure to hypoxia or HO treatment. Moreover, the livers of mice with CCl-induced fibrosis showed a progressive increase in HIF-1α association with the mitochondria, indicating the clinical relevance of this finding. To probe the function of this HIF-1α population, we ectopically expressed a mitochondrial-targeted form of HIF-1α (mito-HIF-1α). Expression of mito-HIF-1α was sufficient to attenuate apoptosis induced by exposure to hypoxia or HO-induced oxidative stress. Moreover, mito-HIF-1α expression reduced the production of reactive oxygen species, the collapse of mitochondrial membrane potential, and the expression of mitochondrial DNA-encoded mRNA in response to hypoxia or HO treatment independently of nuclear pathways. These data suggested that mitochondrial HIF-1α protects against oxidative stress induced-apoptosis independently of its well-known role as a transcription factor.
Hao Z, Guan W, Wei W, Li M, Xiao Z, Sun Q J Neuroinflammation. 2025; 22(1):84.
PMID: 40089793 DOI: 10.1186/s12974-025-03405-7.
Marcinek A, Katarzynska J, Gebicki J Front Physiol. 2025; 16:1509159.
PMID: 40046184 PMC: 11879957. DOI: 10.3389/fphys.2025.1509159.
Yang T, Shao Y, Cheng Q, He Y, Qiu Z, Pan D Acta Pharmacol Sin. 2025; .
PMID: 40038466 DOI: 10.1038/s41401-025-01498-7.
Yang S, Cui Y, Ma R, Yu S, Zhang H, Zhao P Biomolecules. 2025; 15(2).
PMID: 40001559 PMC: 11853270. DOI: 10.3390/biom15020256.
Research progress of HIF-1a on immunotherapy outcomes in immune vascular microenvironment.
Shi S, Ou X, Liu C, Wen H, Ke J Front Immunol. 2025; 16:1549276.
PMID: 39981236 PMC: 11839635. DOI: 10.3389/fimmu.2025.1549276.